| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2875583 | The Annals of Thoracic Surgery | 2011 | 9 Pages |
Abstract
Only a few recipient and operative factors were identified for AR after LTx. Moderately sensitized recipients identified by class II PRA exceeding 10% and those with HLA mismatches at the B and DR loci appear to be more susceptible to AR; however, such immunologic variations appear to be well controlled with current donor selection and immunosuppression protocols. The impact of donor-specific variables on AR is surprisingly strong and warrants closer inspection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abeel A. MD, David P. MD, Edward R. MD, MS, Lillian H. MS, Sudish C. MD, PhD, Diane J. PhD, Robin K. MD, Kenneth R. MD, Gösta B. MD, PhD, Eugene H. MD,